Literature DB >> 3036537

Bovine leukemia virus replicates in sheep B lymphocytes under a T cell released factor.

S Djilali, A L Parodi, D Levy.   

Abstract

In order to determine which cell supports BLV replication in experimentally infected sheep, peripheral blood lymphocytes (PBL) were separated into purified B and T populations by a panning technique. Our data demonstrate that viral replication takes place only in B lymphocytes. However, PHA, a T cell mitogen, is necessary for BLV replication both in PBL and enriched surface immunoglobulin bearing cells, whereas B cell mitogens have no effect on viral replication. Altogether, these results suggest that BLV activation in enriched B lymphocytes is dependent on the presence of residual T cells, and occurs through a T cell interaction, probably mediated by a soluble factor. This possibility was confirmed by the fact that the conditioned medium from cultures of BLV-free sheep T lymphocytes greatly enhances viral production by infected B lymphocytes. Our data favor the hypothesis that BLV multiplication occurs through the regular activation mechanisms of the immune system.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3036537     DOI: 10.1016/0277-5379(87)90423-8

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN: 0277-5379


  6 in total

1.  Construction of a recombinant bovine leukemia virus vector for analysis of virus infectivity.

Authors:  D Derse; L Martarano
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

2.  Transcriptional activation of bovine leukemia virus in blood cells from experimentally infected, asymptomatic sheep with latent infections.

Authors:  D M Lagarias; K Radke
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

3.  Defibrinated bovine plasma inhibits retroviral transcription by blocking p52 activation of the NFkappaB element in the long terminal repeat.

Authors:  Marianne J van den Heuvel; Karen F Copeland; Elizabeth C Cates; Barbara J Jefferson; Robert M Jacobs
Journal:  Can J Vet Res       Date:  2007-04       Impact factor: 1.310

4.  In vivo protein binding and functional analysis of cis-acting elements in the U3 region of the bovine leukemia virus long terminal repeat.

Authors:  J Xiao; G C Buehring
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

5.  Inhibition of protein kinase C results in decreased expression of bovine leukemia virus.

Authors:  W A Jensen; B J Wicks-Beard; G L Cockerell
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

Review 6.  Mechanisms of leukemogenesis induced by bovine leukemia virus: prospects for novel anti-retroviral therapies in human.

Authors:  Nicolas Gillet; Arnaud Florins; Mathieu Boxus; Catherine Burteau; Annamaria Nigro; Fabian Vandermeers; Hervé Balon; Amel-Baya Bouzar; Julien Defoiche; Arsène Burny; Michal Reichert; Richard Kettmann; Luc Willems
Journal:  Retrovirology       Date:  2007-03-16       Impact factor: 4.602

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.